| Product Code: ETC10815150 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Ireland continued to see a diverse range of countries exporting small molecule APIs, with China, Singapore, UK, USA, and Netherlands leading the pack. The market remained competitive with a low Herfindahl-Hirschman Index indicating low concentration. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 10.73%, with a notable growth spurt of 44.88% from 2023 to 2024. This suggests a robust and expanding market for small molecule API imports in Ireland, driven by a mix of global suppliers.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Small Molecule API Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Small Molecule API Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Small Molecule API Market - Industry Life Cycle |
3.4 Ireland Small Molecule API Market - Porter's Five Forces |
3.5 Ireland Small Molecule API Market Revenues & Volume Share, By API Type, 2021 & 2031F |
3.6 Ireland Small Molecule API Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Ireland Small Molecule API Market Revenues & Volume Share, By Manufacturing Process, 2021 & 2031F |
3.8 Ireland Small Molecule API Market Revenues & Volume Share, By Regulatory Approval, 2021 & 2031F |
3.9 Ireland Small Molecule API Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ireland Small Molecule API Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for generic drugs globally |
4.2.2 Growing prevalence of chronic diseases requiring pharmaceutical interventions |
4.2.3 Favorable government initiatives supporting pharmaceutical manufacturing in Ireland |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for API manufacturing |
4.3.2 Rising competition from emerging markets offering lower production costs |
5 Ireland Small Molecule API Market Trends |
6 Ireland Small Molecule API Market, By Types |
6.1 Ireland Small Molecule API Market, By API Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Small Molecule API Market Revenues & Volume, By API Type, 2021 - 2031F |
6.1.3 Ireland Small Molecule API Market Revenues & Volume, By Synthetic APIs, 2021 - 2031F |
6.1.4 Ireland Small Molecule API Market Revenues & Volume, By Semi-Synthetic APIs, 2021 - 2031F |
6.1.5 Ireland Small Molecule API Market Revenues & Volume, By Natural Extract APIs, 2021 - 2031F |
6.1.6 Ireland Small Molecule API Market Revenues & Volume, By High-Potency APIs (HPAPIs), 2021 - 2031F |
6.1.7 Ireland Small Molecule API Market Revenues & Volume, By Peptide-Based APIs, 2021 - 2031F |
6.2 Ireland Small Molecule API Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Ireland Small Molecule API Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.3 Ireland Small Molecule API Market Revenues & Volume, By Oncology Treatments, 2021 - 2031F |
6.2.4 Ireland Small Molecule API Market Revenues & Volume, By Neurology & CNS Disorders, 2021 - 2031F |
6.2.5 Ireland Small Molecule API Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.2.6 Ireland Small Molecule API Market Revenues & Volume, By Respiratory Disorders, 2021 - 2031F |
6.3 Ireland Small Molecule API Market, By Manufacturing Process |
6.3.1 Overview and Analysis |
6.3.2 Ireland Small Molecule API Market Revenues & Volume, By Fermentation-Based, 2021 - 2031F |
6.3.3 Ireland Small Molecule API Market Revenues & Volume, By Chemical Synthesis, 2021 - 2031F |
6.3.4 Ireland Small Molecule API Market Revenues & Volume, By Enzymatic Process, 2021 - 2031F |
6.3.5 Ireland Small Molecule API Market Revenues & Volume, By Supercritical Fluid Tech, 2021 - 2031F |
6.3.6 Ireland Small Molecule API Market Revenues & Volume, By Nanoparticle Synthesis, 2021 - 2031F |
6.4 Ireland Small Molecule API Market, By Regulatory Approval |
6.4.1 Overview and Analysis |
6.4.2 Ireland Small Molecule API Market Revenues & Volume, By FDA Approved, 2021 - 2031F |
6.4.3 Ireland Small Molecule API Market Revenues & Volume, By EMA Certification, 2021 - 2031F |
6.4.4 Ireland Small Molecule API Market Revenues & Volume, By GMP Compliant, 2021 - 2031F |
6.4.5 Ireland Small Molecule API Market Revenues & Volume, By US Pharmacopeia Standard, 2021 - 2031F |
6.4.6 Ireland Small Molecule API Market Revenues & Volume, By International Pharmacopeia, 2021 - 2031F |
6.5 Ireland Small Molecule API Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Ireland Small Molecule API Market Revenues & Volume, By Pharmaceutical Industry, 2021 - 2031F |
6.5.3 Ireland Small Molecule API Market Revenues & Volume, By Biopharmaceuticals, 2021 - 2031F |
6.5.4 Ireland Small Molecule API Market Revenues & Volume, By Generic Drug Production, 2021 - 2031F |
6.5.5 Ireland Small Molecule API Market Revenues & Volume, By Contract Manufacturing (CMO), 2021 - 2031F |
6.5.6 Ireland Small Molecule API Market Revenues & Volume, By Specialty Drugs, 2021 - 2031F |
7 Ireland Small Molecule API Market Import-Export Trade Statistics |
7.1 Ireland Small Molecule API Market Export to Major Countries |
7.2 Ireland Small Molecule API Market Imports from Major Countries |
8 Ireland Small Molecule API Market Key Performance Indicators |
8.1 Percentage of API manufacturing facilities in Ireland meeting regulatory compliance standards |
8.2 Average time taken for regulatory approval of new APIs in Ireland |
8.3 Number of partnerships between Irish API manufacturers and global pharmaceutical companies |
9 Ireland Small Molecule API Market - Opportunity Assessment |
9.1 Ireland Small Molecule API Market Opportunity Assessment, By API Type, 2021 & 2031F |
9.2 Ireland Small Molecule API Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Ireland Small Molecule API Market Opportunity Assessment, By Manufacturing Process, 2021 & 2031F |
9.4 Ireland Small Molecule API Market Opportunity Assessment, By Regulatory Approval, 2021 & 2031F |
9.5 Ireland Small Molecule API Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ireland Small Molecule API Market - Competitive Landscape |
10.1 Ireland Small Molecule API Market Revenue Share, By Companies, 2024 |
10.2 Ireland Small Molecule API Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here